Katri S. Selander
Impact in
- Oncology top 1%
- Bone health and treatments
- Cancer Cells and Metastasis
- Cancer Diagnosis and Treatment
- Immunology top 2%
- Immune Response and Inflammation
Papers in
- Immunology 26
- Immune Response and Inflammation 21
- Oncology 32
- Bone health and treatments 19
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Kevin W. HarrisMark DallasJuan Juan YinJohn M. ChirgwinBarry G. GrubbsPetri LehenkariJoan MassaguéRotraud Wieser
- Journals
- Breast Cancer Research and Treatment (7 papers)Cancer Research (4 papers)The Prostate (3 papers)Frontiers in Immunology (3 papers)European Journal of Pharmacology (3 papers)
- Partner nations
- FinlandUnited StatesItaly
In The Last Decade
Katri S. Selander
62 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 1.9k
- Immunology 965
- Cancer Research 541
- Orthopedics and Sports Medicine 295
- Molecular Biology 1.5k
Countries citing papers authored by Katri S. Selander
This map shows the geographic impact of Katri S. Selander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katri S. Selander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katri S. Selander more than expected).
Fields of papers citing papers by Katri S. Selander
This network shows the impact of papers produced by Katri S. Selander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katri S. Selander. The network helps show where Katri S. Selander may publish in the future.
Co-authors
The 25 scholars most cited alongside Katri S. Selander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 52 | |
| 4 | 2017 | 11 | |
| 5 | 2013 | 34 | |
| 6 | 2013 | 21 | |
| 7 | 2013 | 39 | |
| 8 | 2012 | 58 | |
| 9 | 2011 | 42 | |
| 10 | 2009 | 56 | |
| 11 | 2008 | 75 | |
| 12 | 2008 | 100 | |
| 13 | 2007 | 33 | |
| 14 | Fibroblast growth factor 8 induces osteoclast differentiation in vitro and increases experimental bone metastasis of MDA-MB-231 breast cancer cells in vivo in nude mice | 2006 | 1 |
| 15 | 2006 | 51 | |
| 16 | 2006 | 10 | |
| 17 | 2003 | 23 | |
| 18 | TGF β signaling in osteolytic cancer cell lines: Stimulation of IL-6, IL-11, PTHrP, and VEGF through MAP kinase pathways | 2001 | 2 |
| 19 | TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development Hit paper breakdown → | 1999 | 766 |
| 20 | 1998 | 47 |
About Katri S. Selander
Katri S. Selander is a scholar working on Immunology, Oncology, Cancer Research, Microbiology and Physiology, having authored 63 papers that have together received 3.5k indexed citations. Recurring topics across this work include Immune Response and Inflammation (21 papers), Bone health and treatments (19 papers), Bone Metabolism and Diseases (14 papers), Neonatal Respiratory Health Research (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), NF-κB Signaling Pathways (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Antimicrobial Peptides and Activities (5 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (965 citations), Cancer Research (541 citations), Orthopedics and Sports Medicine (295 citations) and Molecular Biology (1.5k citations). Katri S. Selander has collaborated with scholars based in Finland, United States and Italy. Frequent co-authors include Kevin W. Harris, Mark Dallas, Juan Juan Yin, John M. Chirgwin, Barry G. Grubbs, Petri Lehenkari, Joan Massagué, Rotraud Wieser, G R Mundy and Theresa Guise. Their work appears in journals such as Breast Cancer Research and Treatment, Cancer Research, The Prostate, Frontiers in Immunology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.